Tianjin TEDA Biomedical Engineering Co (HKSE:08189) Beta: 0.1483 (As of Aug. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08189 Tianjin TEDA Biomedical Engineering Co Ltd HKSE:08189
28 GF Score
Price HK$0.26
GF Value HK$0.19
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Tianjin TEDA Biomedical Engineering Co Beta?

Tianjin TEDA Biomedical Engineering Co HKSE:08189 -1.92% 28 Beta is 0.1483 as of Aug. 28, 2026. GuruFocus rates HKSE:08189 with a GF Score™ of 28/100 and a GF Value™ of HK$0.19 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-28), Tianjin TEDA Biomedical Engineering Co's Beta is 0.1483.


Tianjin TEDA Biomedical Engineering Co  (HKSE:08189) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Tianjin TEDA Biomedical Engineering Co Beta Related Terms


Tianjin TEDA Biomedical Engineering Co Beta Historical Data

* Premium members only.

The historical data trend for Tianjin TEDA Biomedical Engineering Co's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tianjin TEDA Biomedical Engineering Co Beta Chart

Tianjin TEDA Biomedical Engineering Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.11 0.31 0.02 0.36

Tianjin TEDA Biomedical Engineering Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.02 0.02 0.05 0.36

HKSE:08189 vs CTVA, CF, MOS: Beta Comparison

For the Agricultural Inputs subindustry, Tianjin TEDA Biomedical Engineering Co's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin TEDA Biomedical Engineering Co Beta vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Tianjin TEDA Biomedical Engineering Co's Beta distribution charts can be found below:

* The bar in red indicates where Tianjin TEDA Biomedical Engineering Co's Beta falls into.


HKSE:08189
28GF Score
Tianjin TEDA Biomedical Engineering Co Ltd HKSE:08189
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tianjin TEDA Biomedical Engineering Co Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1483 mean?
Tianjin TEDA Biomedical Engineering Co (HKSE:08189) has a Beta of 0.1483 as of Aug. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tianjin TEDA Biomedical Engineering Co and its competitors.
Is Tianjin TEDA Biomedical Engineering Co's Beta too high?
Tianjin TEDA Biomedical Engineering Co's current Beta is 0.1483. Overall, Tianjin TEDA Biomedical Engineering Co has a GF Score™ of 28/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Tianjin TEDA Biomedical Engineering Co's Beta compare to CTVA and CF?
Tianjin TEDA Biomedical Engineering Co's Beta of 0.1483 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Agriculture company?
A good Beta depends on the Agriculture industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Tianjin TEDA Biomedical Engineering Co and its competitors. Tianjin TEDA Biomedical Engineering Co's current Beta is 0.1483. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tianjin TEDA Biomedical Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co (HKSE:08189) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.19, compared to a current price of HK$0.26 — trading 34.2% above its estimated fair value. The current Beta is 0.1483. Tianjin TEDA Biomedical Engineering Co's overall GF Score™ is 28/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Tianjin TEDA Biomedical Engineering Co (HKSE:08189), the current Beta is 0.1483 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tianjin TEDA Biomedical Engineering Co (HKSE:08189) Overvalued in 2026?

Based on GuruFocus' analysis, Tianjin TEDA Biomedical Engineering Co stock appears to be overvalued. The current stock price of HK$0.26 is trading 34.2% above its estimated GF Value™ of HK$0.19. GuruFocus considers Tianjin TEDA Biomedical Engineering Co to be Significantly Overvalued.

Key valuation signals for HKSE:08189:

  • Beta: 0.1483
  • GF Value™: HK$0.19 vs. price of HK$0.26 (34.2% above fair value)
  • GF Score™: 28/100 with 8 warning signs

No single metric tells the full story. See the HKSE:08189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tianjin TEDA Biomedical Engineering Co Business Description

Other Exchanges TJJ:Germany
Address No. 80, The 4th Avenue, 9th Floor, Block A2, Tianda Hi-Tech Park, TEDA Tianjin, Tianjin, CHN
Tianjin TEDA Biomedical Engineering Co Ltd principally engages in manufacture and sale of biological compound fertiliser products and elderly care and health care services and related products. The group is principally engaged in manufacturing and selling biological compound fertilisers, AI health & elderly care products and services. It operates in two segments namely; fertilisers products; and AI health & elderly care products and services. The company generates a majority of its revenue from the Fertilisers products segment. The People's Republic of China is the primary geographical market for the company.
28GF Score

Get the complete analysis for HKSE:08189

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.26
Price
HK$0.19
GF Value